Predictors of depression in breast cancer patients treated with radiation: Role of prior chemotherapy and nuclear factor kappa B

Cancer

Volumn 119, Issue 11, 2013, Pages 1951-1959

  Torres, Mylin A ^a   Pace, Thaddeus W ^a   Liu, Tian ^a   Felger, Jennifer C ^a   Mister, Donna ^a   Doho, Gregory H ^b   Kohn, Jordan N ^a   Barsevick, Andrea M ^c   Long, Qi ^d   Miller, Andrew H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

breast cancer; chemotherapy; depression; inflammation; nuclear factor kappa B; radiation

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DNA BINDING; EDUCATIONAL STATUS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY SELF REPORT; MAJOR CLINICAL STUDY; MEDIATOR; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ATTITUDE; PREDICTION; PRIORITY JOURNAL; STRESS;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEPRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MIDDLE AGED; NF-KAPPA B; RADIATION INJURIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878016773     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28003     Document Type: Article

References (39)

1. Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM,. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast. 2010; 19: 84-91.
2. Kawase E, Karasawa K, Shimotsu S, et al. Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. Breast Cancer. 2012; 19: 147-152.
3. Noal S, Levy C, Hardouin A, et al. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011; 81: 795-803.
4. Luutonen S, Vahlberg T, Eloranta S, Hyvari H, Salminen E,. Breast cancer patients receiving postoperative radiotherapy: distress, depressive symptoms and unmet needs of psychosocial support. Radiother Oncol. 2011; 100: 299-303.
5. Khan F, Amatya B, Pallant JF, Rajapaksa I,. Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast. 2012; 21: 314-320.
6. Courtier N, Gambling T, Enright S, Barrett-Lee P, Abraham J, Mason MD,. Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early stage breast cancer. Support Care Cancer. 2013; 21: 173-181.
7. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D,. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011; 29: 413-420.
8. Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI,. The effect of psychosocial factors on breast cancer outcome: a systematic review [serial online]. Breast Cancer Res. 2007; 9: R44.
9. Satin JR, Linden W, Phillips MJ,. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009; 115: 5349-5361.
10. Early Breast Cancer Trialists' Collaborative Group (EBCTCG);, Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378: 1707-1716.
11. Merriman JD, Dodd M, Lee K, et al. Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. Cancer Nurs. 2011; 34: 345-353.
12. Hopwood P, Haviland J, Mills J, Sumo G, Bliss M,. START Trial Management Group. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast. 2007; 16: 241-251.
13. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A,. Depression and anxiety in women with early breast cancer: 5 year observational cohort study [serial online]. BMJ. 2005; 330: 702.
14. Bardwell WA, Natarajan L, Dimsdale JE, et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early stage breast cancer. J Clin Oncol. 2006; 24: 2420-2427.
15. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR,. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008; 26: 971-982.
16. Monk JP, Phillips G, Waite R, et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol. 2006; 24: 1852-1859.
17. Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009; 15: 5534-5540.
18. Wratten C, Kilmurray J, Nash S, et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys. 2004; 59: 160-167.
19. Geinitz H, Zimmermann FB, Stoll P, et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys. 2001; 51: 691-698.
20. DiDonato JA, Mercurio F, Karin M,. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012; 246: 379-400.
21. Braunstein S, Formenti SC, Schneider RJ,. Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells. Mol Cancer Res. 2008; 6: 78-88.
22. Bower JE, Ganz PA, Irwin MR, Arevalo JM, Cole SW,. Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun. 2011; 25: 147-150.
23. Hernandez-Vargas H, Rodriguez-Pinilla SM, Julian-Tendero M, et al. Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007; 102: 157-172.
24. International Commission on Radiation Units and Measurements (ICRU). ICRU Report No. 50: Prescribing, Recording and Reporting Photon Beam Therapy. ICRU: Bethesda, MD; 1993.
25. Nezu AM,. Practitioner's guide to empirically based measures of depression. New York: Kluwer Academic/Plenum Publishers; 2000.
26. Jenkins C, Carmody TJ, Rush AJ,. Depression in radiation oncology patients: a preliminary evaluation. J Affect Disord. 1998; 50: 17-21.
27. Purcell A, Fleming J, Bennett S, Burmeister B, Haines T,. Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer. 2010; 18: 307-315.
28. Albuquerque K, Tell D, Lobo P, Millbrandt L, Mathews H, Witek-Janusek L,. Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer [serial online]. BMC Cancer. 2012; 12: 251.
29. Pace TW, Mletzko TC, Alagbe O, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry. 2006; 163: 1630-1633.
30. Bolstad BM, Irizarry RA, Astrand M, Speed TP,. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003; 19: 185-193.
31. Cole SW, Galic Z, Zack JA,. Controlling false-negative errors in microarray differential expression analysis: a PRIM approach. Bioinformatics. 2003; 19: 1808-1816.
32. Huang da W, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4: 44-57.
33. Shmelkov E, Tang Z, Aifantis I, Statnikov A,. Assessing quality and completeness of human transcriptional regulatory pathways on a genome-wide scale [serial online]. Biol Direct. 2011; 6: 15.
34. Das KC, White CW,. Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. J Biol Chem. 1997; 272: 14914-14920.
35. Raison CL, Borisov AS, Majer M, et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry. 2009; 65: 296-303.
36. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS,. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A. 2010; 107: 2669-2674.
37. Perera TD, Lu D, Thirumangalakudi L, et al. Correlations between hippocampal neurogenesis and metabolic indices in adult nonhuman primates. Neural Plast. 2011; 2011: 1-6.
38. Yamamoto M, Ito T, Shimizu T, et al. Epigenetic alteration of the NF-kappaB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci. 2010; 101: 2391-2397.
39. Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW,. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011; 29: 3517-3522.